Inventor

BROWNING JEFFREY

US21 patents

⚠️ This page may combine multiple inventors who share the name “BROWNING JEFFREY”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BROWNING JEFFREY

BIOGEN IDEC INC

Methods of treatment by administering an anti-BCMA antibody

BAFF, inhibitors thereof and their use in the modulation of B-cell response

BAFF receptor (BCMA), an immunoregulatory agent

Tumor necrosis factor related ligand

Tumor necrosis factor related ligand

Tweak receptor agonists as anti-angiogenic agents

Antibodies specifically reactive with a tumor necrosis factor related ligand

Tumor necrosis factor related ligand

TWEAK receptor agonists as anti-angiogenic agents

Active lymphotoxin-β receptor immunoglobulin chimeric protein compositions

BIOGEN INC

Lymphotoxin-beta and lymphotoxin-beta complexes

Lymphotoxin-β, Lymphotoxin-β complexes, pharmaceutical preparations and therapeutic uses thereof

Lymphotoxin-β, lymphotoxin-β complexes, pharmaceutical preparations and therapeutic uses thereof

BROWNING JEFFREY

Methods of screening for a compound that inhibits the interaction between BAFF and BCMA

Method for increasing expression of active tumor necrosis factor receptor family member-Ig fusion proteins

Treatment of follicular lymphomas using inhibitors of the LT pathway

BIOGEN MA INC

Methods of treating autoimmune diseases using a B-cell maturation antigen (BCMA)

Methods of modulating immune responses using BCMA polypeptide

UNIV CALIFORNIA

Lymphotoxin-β, lymphotoxin-β complexes, pharmaceutical preparations and therapeutic uses thereof

UNIV NEW YORK

Treatment of follicular lymphomas using inhibitors of the LT pathway

FACULTY OF MEDICINE OF THE UNI

Tumor necrosis factor related ligand